Background on Sun Pharma and its Relevance
Sun Pharmaceutical Industries Ltd., an Indian-origin pharmaceutical company, has been identified by the Mexican federal government for failing to deliver medications as committed. The company has stated that it possesses 100% of the required medications ready for immediate distribution, but faces logistical challenges in receiving and delivering these products.
Government’s Allegations
During President Claudia Sheinbaum’s morning press conference on September 23, Eduardo Clark, the subsecretary of Integration and Development of the Health Sector, reported that Sun Pharma had breached 63.5% of its commitment to supply 71,848 medical products for the period 2025-2026. The company has only delivered 26,240 pieces so far.
Sun Pharma’s Perspective
In a statement released on Friday, Sun Pharma emphasized that their primary obstacle is not product availability or capacity but rather logistical coordination issues faced by the public health sector, including delivery delays, product rejections due to warehouse saturation, and order cancellations.
“It is crucial to clarify that this non-compliance does not stem from a lack of product; instead, Sun Pharma has 100% of these medications and the required lots in Mexico, ready for immediate delivery,” said Carlos Estrada, the company’s general manager.
The pharmaceutical firm urged authorities to facilitate the allocation and efficient management of receiving appointments. Sun Pharma confirmed its full capability to deliver the 40,590 pending pieces “immediately” and requested urgent coordination to overcome logistical challenges with the Mexican government.
Legal Context
Regarding the 2024 amparo obtained against a 40-month disablement imposed by the former Secretariat of Public Function, Sun Pharma explained that this legal action aimed to protect its operational capacity and ensure the supply of essential medications for Mexico’s healthcare system.
“This legal process is following the established course. This action was taken solely to protect the company’s operational capacity and ensure the flow of essential medications,” Estrada stated.
Sun Pharma’s History and Impact
Sun Pharma has been a supplier to Mexico’s public health sector for over 20 years, providing medications in therapeutic areas such as psychiatry and oncology.
Key Questions and Answers
- What is the issue at hand? Sun Pharma claims it has all medications ready for delivery but faces logistical challenges in receiving and distributing them.
- What did the Mexican government report? The federal government stated that Sun Pharma has breached 63.5% of its commitment to supply 71,848 medical products for the period 2025-2026.
- What is Sun Pharma’s stance? The company asserts that their primary obstacle is logistical coordination issues, not product availability or capacity.
- What is the legal context? Sun Pharma obtained an amparo in 2024 to protect its operational capacity and ensure the supply of essential medications.
- How long has Sun Pharma been operating in Mexico? The company has supplied medications to Mexico’s public health sector for more than 20 years.
